Previously, our group reported that WFA treatment reduced inflammation in the spinal cord and rescued the motor pathology in transgenic mice expressing TDP-43 mutants, models of ALS/FTLD [15]. Here, TARDBP is linked to amyotrophic lateral sclerosis.